PTPIOTCPharmaceutical PreparationsFiscal year ends December 31
Petros Pharmaceuticals, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$0.00+0.00 (+5.56%)
Close on Oct 19, 2026
- Market cap
- $135.07K
- P/E (TTM)
- –
- Dividend yield
- –
Price history
Daily open, high, low, close and volume
| Date | Open | High | Low | Close | Change | Volume |
|---|---|---|---|---|---|---|
| Daily prices are not in StockData yet. This table fills in once an end-of-day price source is connected. | ||||||
Stock splits
From SEC filings
| Date | Ratio | Effect on per-share figures |
|---|---|---|
| May 1, 2025 | 1-for-25 reverse | Earlier per-share figures multiplied by 25 |
| Apr 29, 2025 | 1-for-25 reverse | Earlier per-share figures multiplied by 25 |
| Dec 1, 2022 | 1-for-10 reverse | Earlier per-share figures multiplied by 10 |
| Nov 30, 2022 | 1-for-10 reverse | Earlier per-share figures multiplied by 10 |